Revolution Vibe vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Revolution Vibe
by GE HealthCare
VS
Tempus ECG-AF
by Tempus AI, Inc.

AI Verdict

Revolution Vibe is an AI-powered CT imaging system designed for detailed cardiac anatomical and functional assessment through high-quality scans. In contrast, Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECGs to predict the risk of future atrial fibrillation. While both are cardiology AI tools, they serve distinct purposes: one for advanced diagnostic imaging and the other for predictive risk stratification based on ECG data.

Choose Revolution Vibe if…

Choose Revolution Vibe if your facility requires a cutting-edge CT imaging system for comprehensive and highly detailed cardiac anatomical assessment. This tool is ideal for advanced coronary CT angiography (CCTA), complex cardiac cases, and situations demanding low-dose, high-resolution imaging for precise diagnosis and treatment planning, even in challenging patients with arrhythmias or breath-holding difficulties.

View Revolution Vibe →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your clinical practice aims to proactively identify older patients (65+) at an increased risk of developing new-onset atrial fibrillation within the next 12 months. This AI-based software solution is best suited for integrating into existing cardiology workflows to analyze standard 12-lead ECGs, supporting earlier risk stratification and guiding targeted follow-up for at-risk individuals without a prior AF diagnosis or specific cardiac devices.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Revolution Vibe Tempus ECG-AF
Pricing Contact vendor for quote Contact vendor
Deployment On-premise (physical medical device installation) Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Revolution Vibe Tempus ECG-AF
Product Name Revolution Vibe Tempus ECG-AF
Company GE HealthCare Tempus AI, Inc.
Primary Function AI-powered CT system optimized for advanced cardiac imaging, including Coronary CT Angiography (CCTA), delivering high-quality, low-dose images with streamlined workflows. FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Target Patient Population/Use Case Patients requiring advanced cardiac imaging, including CCTA, for full-heart clarity at low dose. Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to identify increased risk of developing AF within 12 months.
Key Technology/Methodology AI-powered CT system with features like Unlimited One-Beat Cardiac imaging, AI-powered Effortless Cardiac Workflow, ECG-less Cardiac CT, TrueFidelity DL, SnapShot Freeze 2. AI-based algorithm for 12-lead ECG analysis, trained on over 1.5 million ECGs.

Videos

Demos, reviews, and walkthroughs featuring Revolution Vibe and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

GE HealthCare's Revolution Vibe is an AI-powered CT system designed for advanced cardiac imaging, including Coronary CT Angiography (CCTA), to deliver high-quality, low-dose images. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Revolution Vibe is optimized for advanced cardiac imaging for a broad range of patients, including those with challenging conditions like irregular heart rhythms or heavily calcified arteries. Tempus ECG-AF is intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to assess their risk of developing AF within 12 months.
For Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T, assigned to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025. Revolution Vibe's pricing is not publicly available and is typically negotiated directly with GE HealthCare.
Revolution Vibe offers Unlimited One-Beat Cardiac imaging for full-heart clarity at low dose, TrueFidelity DL, and SnapShot Freeze 2 for motion-free, high-quality image reconstruction. Tempus ECG-AF's key feature is its AI-based algorithm for 12-lead ECG analysis, trained on over 1.5 million ECGs, to detect signs associated with new onset Atrial Fibrillation.
Revolution Vibe features an AI-powered Effortless Cardiac Workflow for automated protocol selection and patient positioning, and ECG-less Cardiac CT for simplified patient preparation. Tempus ECG-AF supports earlier identification and follow-up for patients at risk of AF, and is designed to work with existing ECG platforms and EHRs.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Revolution Vibe or Tempus ECG-AF

AI Tool Finder
AI-powered search. Results may not be comprehensive.